Cardiovascular diseases (CVDs) are the leading causes of death worldwide, both in men and women. It is estimated that approximately 17 million people die of CVDs in the world every year and almost 23.6 million people will die from CVDs by 2030. Despite advances in prevention and treatment over the past decades, CVDs patients are still confronted with a reduction in lifespan and quality of life. Herbal medicines from different traditions play a significant role in preventing and treating CVDs with lower costs and fewer side effects and for some of these preparations a sound evidence base exists.
For example, specific Chinese medical preparation may help to regulate metabolism and have pro-angiogenetic, anti-fibrosis, anti-inflammatory, antioxidative, anti-apoptotic, and anti-oxidative effects. Similarly, other medical systems not only in Asia have records on plants used for treating cardiovascular diseases and their prevention. A famous example includes the use of hawthorn (Crataegus spp.) e.g., in European phytotherapy. In addition, it is more likely that the combined application of herbal and chemical drugs could be more effective in preventing and treating CVDs. However, more clinical evidence and definite potential mechanisms are still needed to elucidate the roles of herbal medicine in CVDs.
Therefore, we invite authors to contribute the review and original research articles that provide a rigorous and critical assessment of the application of herbal medicines in the prevention and treatment of CVDs and the limitations of such applications. In particular, we are interested in articles exploring mechanisms of action through experimental research. Randomized controlled trials (RCT), systematic reviews, and meta-analyses in the relevant field are also welcome. Potential topics include, but are not limited to:
• Ethnopharmacological studies of herbal medicine used in the treatment of CVDs
• Advances in assessing mechanisms of action of herbal medicine in preventing and treating CVDs
• Advances in identifying active ingredients of herbal medicine against CVDs
• Systematic review and meta-analysis of herbal medicine on prophylactic and/or therapeutic treatments of CVDs
• Toxicological effects associated with the use of herbal medicine for CVDs
• RCT of herbal medicine in preventing and treating CVDs
• Clinical practice and experience of the integration of herbal medicine with conventional medicine or western medicine in preventing and treating CVDs
Please note:
Purely in silico studies will not be considered including network analysis or docking studies. You must pay close attention to the Four Pillars of Best Practice and specifically to the requirements for reporting the composition of the preparations under investigation.
Cardiovascular diseases (CVDs) are the leading causes of death worldwide, both in men and women. It is estimated that approximately 17 million people die of CVDs in the world every year and almost 23.6 million people will die from CVDs by 2030. Despite advances in prevention and treatment over the past decades, CVDs patients are still confronted with a reduction in lifespan and quality of life. Herbal medicines from different traditions play a significant role in preventing and treating CVDs with lower costs and fewer side effects and for some of these preparations a sound evidence base exists.
For example, specific Chinese medical preparation may help to regulate metabolism and have pro-angiogenetic, anti-fibrosis, anti-inflammatory, antioxidative, anti-apoptotic, and anti-oxidative effects. Similarly, other medical systems not only in Asia have records on plants used for treating cardiovascular diseases and their prevention. A famous example includes the use of hawthorn (Crataegus spp.) e.g., in European phytotherapy. In addition, it is more likely that the combined application of herbal and chemical drugs could be more effective in preventing and treating CVDs. However, more clinical evidence and definite potential mechanisms are still needed to elucidate the roles of herbal medicine in CVDs.
Therefore, we invite authors to contribute the review and original research articles that provide a rigorous and critical assessment of the application of herbal medicines in the prevention and treatment of CVDs and the limitations of such applications. In particular, we are interested in articles exploring mechanisms of action through experimental research. Randomized controlled trials (RCT), systematic reviews, and meta-analyses in the relevant field are also welcome. Potential topics include, but are not limited to:
• Ethnopharmacological studies of herbal medicine used in the treatment of CVDs
• Advances in assessing mechanisms of action of herbal medicine in preventing and treating CVDs
• Advances in identifying active ingredients of herbal medicine against CVDs
• Systematic review and meta-analysis of herbal medicine on prophylactic and/or therapeutic treatments of CVDs
• Toxicological effects associated with the use of herbal medicine for CVDs
• RCT of herbal medicine in preventing and treating CVDs
• Clinical practice and experience of the integration of herbal medicine with conventional medicine or western medicine in preventing and treating CVDs
Please note:
Purely in silico studies will not be considered including network analysis or docking studies. You must pay close attention to the Four Pillars of Best Practice and specifically to the requirements for reporting the composition of the preparations under investigation.
